General

Elicio Therapeutics Inc. (NASDAQ:ELTX) stock is up on Wednesday as the company reported promising clinical observations regarding its ELI-002 7P treatment. Durable Responses And T-Cell Activity Highlight Potential Benefit The cancer immunotherapy company announced that three patients who received...

Space Exploration Technologies Corp. (NASDAQ:SPCX) didn’t just launch an options market on Tuesday—it rewrote the record books. Roughly 1.8 million SpaceX options contracts changed hands during their first trading session, according to Trade Alert data cited by Reuters. That easily surpassed...

An official report on June 16, 2026 reveals Senator John Boozman's recent sale of iShares 3-7 Year Treasury Bond ETF (NASDAQ:IEI) stock, valued between $64,015 and $310,000. The transaction took place on May 13, 2026, as per the June filing. At this time, iShares 3-7 Year Treasury Bond ETF shares...

A report on June 16, 2026 shows that Representative Jonathan Jackson from Illinois sale stock in Microsoft (NASDAQ:MSFT), valued between $15,001 and $50,000. According to the June filing, the transaction occurred on May 12, 2026. At the time of writing, Microsoft shares are trading down 1.96% at $...

Ocular Therapeutix, Inc. (NASDAQ:OCUL) stock is trading higher on Wednesday as the company prepares for its Investor Day, where it will detail its plans for submitting a New Drug Application (NDA) for AXPAXLI. The stock’s decline comes amid a mixed market backdrop, with S&P 500 futures...

uniQure N.V. (NASDAQ:QURE) stock is up during Wednesday’s premarket session as the company announced plans for a Biologics License Application (BLA) submission for AMT-130, a gene therapy treatment for Huntington’s disease. FDA Opens Accelerated Approval Path This news comes following a...

The space sector is catching its breath Wednesday — and for the first time since SpaceX (NASDAQ:SPCX) went public last week and triggered a sector-wide selloff, many publicly traded space names are green. Momentus Inc. (NASDAQ:MNTS) and AST SpaceMobile, Inc. (NASDAQ:ASTS) are leading the charge...

Kevin Warsh's first meeting as Fed chair is widely expected to deliver the same policy outcome markets have grown accustomed to — another pause. But investors are less focused on this week’s rate decision than on something arguably more consequential: how the new chair plans to communicate...

Perplexity AI co-founder and CEO Aravind Srinivas has predicted that semiconductor giant Micron Technology Inc. (NASDAQ:MU) could soon surpass Meta Platforms Inc. (NASDAQ:META) in market capitalization. Srinivas argues that global tech dominance is shifting entirely toward hardware providers,...

Outlook Therapeutics Inc. (NASDAQ:OTLK) shares are rising in Wednesday premarket trading after the company announced the FDA accepted its resubmitted Biologics License Application (BLA) for ONS-5010/LYTENAVA. The FDA acknowledged receipt of the application on Tuesday. If approved, ONS-5010/LYTENAVA...

The U.S. Food and Drug Administration’s (FDA) Vaccines and Related Biological Products Advisory Committee (VRBPAC) will meet on Thursday, June 18, to discuss approval of Moderna Inc.’s (NASDAQ:MRNA) experimental mRNA-based flu vaccine. FDA Advisory Committee To Review Moderna Flu...

A collapse in crude oil futures prices is poised to deliver savings to American motorists, with top economist Mohamed A. El-Erian predicting that regular gasoline and diesel will crash through the $4 and $5 thresholds, respectively, in the coming days. Imminent Relief at the Pump The nationwide...

For more than two decades, passive investing has been a humble idea successfully marketed to the retail audience. It was a set-and-forget approach – not trying to outsmart the market but simply owning it. Now, according to a growing camp of market critics, passive funds have become something far...

Leaders of the G7, including President Donald Trump, pledged to increase military support for Ukraine and strengthen sanctions targeting Russia’s energy sector in a joint declaration signed Wednesday during the three-day summit in Evian-les-Bains. “We, the Leaders of the G7, stand...

Trump allies and critics erupted online after Reuters reported that a U.S.-Iran framework agreement includes a $300 billion private fund meant to spur investment in Iran, with more than half already committed, alongside separate talks over sanctions relief and frozen Iranian assets. Private Fund...